This inventor holds 2 USPTO granted patents. Top assignee: Studiengesellschaft Kohle Mbh. Active years: 1998-2000.
Company Filing History:
Years Active: 1998-2000
Title: Albin Zonta: Innovator in Lipase Immobilization
Introduction
Albin Zonta is a notable inventor based in Mulheim an der Ruhr, Germany. He has made significant contributions to the field of biochemistry, particularly in the immobilization of lipases. With a total of 2 patents, Zonta's work has implications for medical treatments related to digestive insufficiency.
Latest Patents
Zonta's latest patents focus on innovative methods for immobilizing lipases. One patent describes the immobilization of lipases by entrapment in silica matrices. This process involves the hydrolysis of alkoxy-silicon compounds in the presence of catalysts and various additives, including proteins and polyhydroxy compounds. The entrapped lipase can be utilized for treating digestive insufficiency caused by pancreatic diseases or cystic fibrosis. Another patent details a method for preparing immobilized lipases through reactions on a silica matrix that contains non-hydrolyzable organic substituents attached via Si--C bonds.
Career Highlights
Zonta is associated with Studiengesellschaft Kohle GmbH, where he has been able to apply his innovative ideas in a collaborative environment. His work has been instrumental in advancing the understanding and application of lipase immobilization techniques.
Collaborations
Zonta has collaborated with notable colleagues such as Manfred T Reetz and Jorg Simpelkamp. Their combined expertise has contributed to the successful development of his patented technologies.
Conclusion
Albin Zonta's contributions to the field of lipase immobilization demonstrate his innovative spirit and commitment to advancing biochemistry. His patents not only highlight his technical skills but also have the potential to improve medical treatments for patients with digestive issues.